Literature DB >> 23824286

Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-Analysis.

Lishan Wang1.   

Abstract

OBJECTIVES: To assess the association of polymorphism rs198977 in the human kallikrein-2 gene (KLK2) and risk of prostate cancer (PCa).
METHODS: Two investigators independently searched the PubMed, Elsevier, EMBASE, Web of Science, Wiley Online Library and Chinese National Knowledge Infrastructure (CNKI). Pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) for rs198977 and PCa were calculated in a fixed-effects model (the Mantel-Haenszel method) and a random-effects model (the DerSimonian and Laird method) when appropriate.
RESULTS: Six studies met the inclusion criteria in this meta-analysis, which included 5859 PCa cases and 4867 controls. Overall, rs198977 was associated with the PCa risk (TT+CT vs. CC, pooled OR = 1.163, 95% CI = 1.076-1.258, P-value <0.0001). When stratified by ethnicity, significant association was observed in Caucasian samples under both allele comparison (T vs. C, pooled OR = 1.152, 95% CI = 1.079-1.229, P-value <0.0001) and dominant model (TT+CT vs. CC, pooled OR = 1.197, 95% CI = 1.104-1.297, P-value <0.0001). In the overall analysis, a comparably significant increase in the frequency of allele T for rs198977 was detected between cases and controls in Caucasian.
CONCLUSION: This meta-analysis suggests that rs198977 of KLK2 was associated with susceptibility of PCa in Caucasian and the allele T might increase the risk of PCa in Caucasian.

Entities:  

Year:  2013        PMID: 23824286      PMCID: PMC3688805          DOI: 10.1371/journal.pone.0065651

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  26 in total

1.  Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population?

Authors:  Rama D Mittal; Dhruva K Mishra; K Thangaraj; Rajender Singh; Anil Mandhani
Journal:  Steroids       Date:  2006-12-19       Impact factor: 2.668

Review 2.  Genetic etiology of hereditary prostate cancer.

Authors:  Wendy J Langeberg; William B Isaacs; Janet L Stanford
Journal:  Front Biosci       Date:  2007-05-01

3.  Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene.

Authors:  P H Riegman; R J Vlietstra; J A van der Korput; J C Romijn; J Trapman
Journal:  Biochem Biophys Res Commun       Date:  1989-02-28       Impact factor: 3.575

Review 4.  Tumor markers in prostate cancer I: blood-based markers.

Authors:  Shahrokh F Shariat; Axel Semjonow; Hans Lilja; Caroline Savage; Andrew J Vickers; Anders Bjartell
Journal:  Acta Oncol       Date:  2011-06       Impact factor: 4.089

5.  Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.

Authors:  Rebecca Siegel; Elizabeth Ward; Otis Brawley; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2011-06-17       Impact factor: 508.702

6.  Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis.

Authors:  A W Partin; W J Catalona; J A Finlay; C Darte; D J Tindall; C Y Young; G G Klee; D W Chan; H G Rittenhouse; R L Wolfert; D L Woodrum
Journal:  Urology       Date:  1999-11       Impact factor: 2.649

Review 7.  The new human kallikrein gene family: implications in carcinogenesis.

Authors:  E P Diamandis; G M Yousef; L Y Luo; A Magklara; C V Obiezu
Journal:  Trends Endocrinol Metab       Date:  2000-03       Impact factor: 12.015

8.  Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice.

Authors:  Simon A Williams; Yi Xu; Angelo M De Marzo; John T Isaacs; Samuel R Denmeade
Journal:  Prostate       Date:  2010-05-15       Impact factor: 4.104

9.  Variation in KLK genes, prostate-specific antigen and risk of prostate cancer.

Authors:  Jiyoung Ahn; Sonja I Berndt; Sholom Wacholder; Peter Kraft; Adam S Kibel; Meredith Yeager; Demetrius Albanes; Edward Giovannucci; Meir J Stampfer; Jarmo Virtamo; Michael J Thun; Heather Spencer Feigelson; Geraldine Cancel-Tassin; Olivier Cussenot; Gilles Thomas; David J Hunter; Joseph F Fraumeni; Robert N Hoover; Stephen J Chanock; Richard B Hayes
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

10.  Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.

Authors:  W J Catalona; J P Richie; J B deKernion; F R Ahmann; T L Ratliff; B L Dalkin; L R Kavoussi; M T MacFarlane; P C Southwick
Journal:  J Urol       Date:  1994-12       Impact factor: 7.450

View more
  1 in total

1.  Retraction: Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-Analysis.

Authors: 
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.